NCN Ingredients & Technology Investor Meeting III at SupplySide West brought together 48 investors to view and interact with 11 presenting companies. Information on the presenting companies is available to NCN members from Grant Ferrier (619-295-7685 x15).

Presenter Company Profiles for NCN III at SupplySide West 2011
1. Developer of prebiotic products targeting the microbiome for metabolic conditions
2. Nano-dispersion technology to help get non-water-soluble nutritional compounds into foods, beverages, supplements, HBC and animal products
3. Soy saponin process technology for gut health, IBS and evaluating the prevention of colon cancer
4. Patent protected intra-dermal drug delivery systems and oral hygiene utilizing cGMP and natural ingredient technologies
5. Licensor of a green, anti-microbal technology with applications in personal care products, CPG packaging, surface sanitation, production process and water/liquid filtration
6. Oral probiotic that fights bacteria causing sore throats, colds, flu, ear infections and bad breath
7. Developer of a proprietary bank of  bacterial strains for probiotic ingredients, plus genetic analysis and R&D services
8. Discovery and development of olive polyphenols
9. Developer of effective formulations for cancer inhibition and health of chemotherapy patients
10. Platform technology producing high-concentration, low-cost, egg-based Immunoglobulin for immunity ingredients in food, supplements, HBC and animal products
11. Patented single-shot dispenser of powders into any drinking device

New in 2011 was a Special Educational Session presented by Todd Harrison, Co-Chair of Venable LLP’s Food, Dietary Supplements and Cosmetics Practice. "Bringing Supplements, Medical Foods and Pharmaceuticals to Market" was an interactive session that provided a clear picture of the regulatory tracks for supplements, medical foods and drugs. Lunch was graciously hosted by Venable, NCN's law firm partner.